Company intelligence / Profile preview

Agro BioSciences

Waukesha, Wisconsin, United States

Ownership: Private
Employees: ~36
Development stage: Other

Overview

Agro BioSciences demonstrated efficacy of Bacillus subtilis-based probiotics as alternatives to antibiotics for growth and immune modulation in poultry; its products improved feed efficiency and modulated gut immune responses. The company reached commercial stage before acquisition[1][2].

Therapeutic areas: ImmunologyGastroenterologyInfectious DiseasesMetabolic DisordersOther
Modalities: Live biotherapeutic product therapyProbioticsMicrobial therapy
Industry: Veterinary

Beyond the preview

Go deeper on Agro BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agro BioSciences.

Explore the full profile